Latest Production Development News

Tinybeans Group Limited reports steady subscription revenue and improved cash flow in Q1 FY26, while launching a new iOS Photo Store to diversify income streams and enhance user monetisation.

Adherium Limited reports a strong quarter with a 55% increase in device shipments and groundbreaking clinical results from its iCARE study, alongside securing over $2.6 million in post-quarter funding.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.

InteliCare Holdings reported a $834,000 operating cash outflow for Q3 2025 but bolstered its balance sheet with a $1.8 million capital raise, positioning itself to sustain operations over the coming quarters.

Thrive Tribe Technologies reported a $451,000 net operating cash outflow in Q1 FY26 but bolstered its cash reserves to $589,000 through over $1 million in equity placements. The company progressed its Thrive Tribe Home Base initiative and expanded its digital business units while managing a limited cash runway.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Oakridge International reports robust Q1 2025 results with strong sales and technology advances, while managing a potential legal claim.

McPherson’s Limited updates shareholders on its ongoing transformation journey, reporting modest core brand growth in FY25 and outlining a strategic outlook for FY26 focused on sustainable expansion and operational efficiency.

Spenda Limited reported a record $204 million in payment volumes for Q1 FY26 alongside a strategic cost reduction of 21% annualised. The quarter also saw a significant leadership change with the resignation of its Managing Director.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

Electro Optic Systems (EOS) reports a surge in contract backlog to $415 million, anchored by a landmark $125 million export order for a high-energy laser weapon. Despite a $34.3 million operating cash outflow in Q3, EOS is poised for growth with new defence contracts and product innovations.